Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1851 (LINC01851) is a long non-coding RNA gene located on human chromosome 2 (2:77,915,870-77,918,013, forward strand). It does not encode a protein and is classified as an lncRNA, a class of RNAs that are typically involved in the regulation of gene expression but do not code for proteins. As of the current literature, there is no validated evidence linking LINC01851 to specific biological functions, pathways, or disease mechanisms in humans. It is not recognized as a therapeutic target, receptor, enzyme, transporter, or other druggable gene product. Its clinical utility, biomarker potential, and mechanistic roles remain uncharacterized, with only basic gene and genomic data available as of now.
Not applicable (no known drugs targeting this lncRNA)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1851 (LINC01851).